Related titles	<< BACK
	A Special Report on Gene Therapy Companies K.K. Jain, Basle, Switzerland There are various reports available on the Biotechnology Industry but none that gives such concise, clearly defined information on significant Gene Therapy companies, all of which have been carefully selected and meticulously verified. Click here to see a sample chapter from Jain's Special Report.
This special report by K.K. Jain provides an up-to-date overview of the gene therapy industry together with a wealth of practical information on 105 key companies. Each company has its own specific entry including information on: people to contact, corporate history, technologies and products, financial data, patents held, products in clinical trials, collaborations with other companies and selected publications from the company's scientists. PLUS the appendices present data in summary tabular form so that at a glance you can identify collaborations, strategies and which diseases are being targeted. In such a fast moving industry it is essential that managers, scientists and investors have at their fingertips all the relevant information. This special report provides this in one accurate, easy to consult and up-to-date source. Contents: Introduction - provides an overview of the gene therapy industry such as the history, definitions, basics of gene therapy, different strategies, classifications and the relationship between academia and the gene therapy companies. Company Profiles Contact details - complete details of key people in each company. Corporate Summary - a short overview of the company, including information on financials, location and products. Products - facts on the products, services and technologies the company has to offer. Patents - the company's portfolio of patents covering processes and compositions. Clinical Trials - information on trials the company is involved in or has been involved in. Grants - details on any government or industry grants the company has been awarded. Collaborations - this section deals with agreements or partnerships the company is involved in. Selected Publications - from the Company's Scientists Appendices -the data is presented in summary tabular form so that at a glance the reader can identify collaborations within the gene therapy industry, determine which companies are pursuing strategies involving viral, non-viral or other approaches to gene therapy, and which diseases are being targeted. Some Benefits of this Special Report Unique method of compiling. Concise descriptions including all the important features of 'Finance', 'Patents', 'Technologies' and 'Collaborations'. Completely up-to-date Unique section on 'Selected Publications'. Contact information for key people is listed for each company. Collaborations include both industrial and academic. The company's technology can be reviewed through tabulations. New companies listed that are not referenced in any other report. 0471 492 906February 2000PaperbackPrice £295
Home | Feedback | About Wiley © John Wiley & Sons Ltd, 1999.    (Best viewed with Navigator 4 or MSIE 4 and 16bit colour)